Oragenics, Inc.
OGEN
$0.59
$0.035.45%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -27.97% | 107.00% | |||
| Gross Profit | 27.97% | -107.00% | |||
| SG&A Expenses | -16.65% | 73.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.02% | 82.23% | |||
| Operating Income | 20.02% | -82.23% | |||
| Income Before Tax | 20.96% | -34.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.43% | -34.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.43% | -34.97% | |||
| EBIT | 20.02% | -82.23% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 72.51% | 36.72% | |||
| Normalized Basic EPS | 70.86% | 36.72% | |||
| EPS Diluted | 72.51% | 36.72% | |||
| Normalized Diluted EPS | 70.86% | 36.72% | |||
| Average Basic Shares Outstanding | 171.27% | 113.30% | |||
| Average Diluted Shares Outstanding | 171.27% | 113.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||